BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26108672)

  • 1. Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma.
    Gimenez M; Marie SK; Oba-Shinjo S; Uno M; Izumi C; Oliveira JB; Rosa JC
    BMC Cancer; 2015 Jun; 15():481. PubMed ID: 26108672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsp27 (HSPB1): a possible surrogate molecular marker for loss of heterozygosity (LOH) of chromosome 1p in oligodendrogliomas but not in astrocytomas.
    Castro GN; Cayado-Gutiérrez N; Moncalero VL; Lima P; De Angelis RL; Chávez V; Cuello-Carrión FD; Ciocca DR
    Cell Stress Chaperones; 2012 Nov; 17(6):779-90. PubMed ID: 22806482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of low- to high-grade astrocytomas reveals an alteration of the expression level of raf kinase inhibitor protein and nucleophosmin.
    Gimenez M; Souza VC; Izumi C; Barbieri MR; Chammas R; Oba-Shinjo SM; Uno M; Marie SK; Rosa JC
    Proteomics; 2010 Aug; 10(15):2812-21. PubMed ID: 20533335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
    Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
    Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.
    Nutt CL; Betensky RA; Brower MA; Batchelor TT; Louis DN; Stemmer-Rachamimov AO
    Clin Cancer Res; 2005 Mar; 11(6):2258-64. PubMed ID: 15788675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme.
    Taghian A; Ramsay J; Allalunis-Turner J; Budach W; Gioioso D; Pardo F; Okunieff P; Bleehen N; Urtasun R; Suit H
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):243-9. PubMed ID: 8380568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p-CREB expression in human gliomas: potential use in the differential diagnosis between astrocytoma and oligodendroglioma.
    Barresi V; Mondello S; Branca G; Rajan TS; Vitarelli E; Tuccari G
    Hum Pathol; 2015 Feb; 46(2):231-8. PubMed ID: 25476123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes.
    Senger DL; Tudan C; Guiot MC; Mazzoni IE; Molenkamp G; LeBlanc R; Antel J; Olivier A; Snipes GJ; Kaplan DR
    Cancer Res; 2002 Apr; 62(7):2131-40. PubMed ID: 11929835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp27 and its expression pattern in diffusely infiltrating astrocytomas.
    Mäkelä KS; Haapasalo JA; Ilvesaro JM; Parkkila S; Paavonen T; Haapasalo HK
    Histol Histopathol; 2014 Sep; 29(9):1161-8. PubMed ID: 24599602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iTRAQ-Based Quantitative Proteomic Analysis of Nasopharyngeal Carcinoma.
    Cai XZ; Zeng WQ; Xiang Y; Liu Y; Zhang HM; Li H; She S; Yang M; Xia K; Peng SF
    J Cell Biochem; 2015 Jul; 116(7):1431-41. PubMed ID: 25648846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein expression in human gliomas.
    Strik HM; Weller M; Frank B; Hermisson M; Deininger MH; Dichgans J; Meyermann R
    Anticancer Res; 2000; 20(6B):4457-62. PubMed ID: 11205288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between the expression of O6-methylguanine-DNA methyltransferase in glioma and the survival time of patients].
    Sun YH; Zhang YZ; Wang ZC; Sun MZ; Zhao DH
    Ai Zheng; 2004 Sep; 23(9):1052-5. PubMed ID: 15363200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas.
    Liu Y; Hu H; Zhang C; Wang H; Zhang W; Wang Z; Li M; Zhang W; Zhou D; Jiang T
    Oncotarget; 2015 Nov; 6(35):38257-69. PubMed ID: 26468983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-3 labeling correlates positively in tumor cells and negatively in endothelial cells with malignancy and poor prognosis in oligodendroglioma patients.
    Deininger MH; Trautmann K; Meyermann R; Schluesener HJ
    Anticancer Res; 2002; 22(3):1585-92. PubMed ID: 12168841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
    Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
    OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase expression of glioma in human and animal models.
    Hong X; Nelson KK; deCarvalho AC; Kalkanis SN
    J Neurosurg; 2010 Aug; 113(2):261-9. PubMed ID: 19835469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.